Evidence map›Paper›PMID 25343016›Full record

ArticleToxicological research2014

In Vitro Genotoxicity Assessment of a Novel Resveratrol Analogue, HS-1793.

Min Ho Jeong, Kwangmo Yang, Chang Geun Lee, Dong Hyeok Jeong, You Soo Park, Yoo Jin Choi, Joong Sun Kim, Su Jung Oh, Soo Kyung Jeong, Wol Soon Jo

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genotoxicity of Water Extract from Bark-RemovedMolecules (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?Advances in nutrition (Bethesda, Md.) · 2016
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Min Ho JeongDepartment of Microbiology, Dong-A University College of Medicine, Busan, Korea.
Kwangmo YangDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Chang Geun LeeDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Dong Hyeok JeongDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
You Soo ParkDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Yoo Jin ChoiDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Joong Sun KimDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Su Jung OhDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Soo Kyung JeongDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Wol Soon JoDepartment of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan, Korea.
Dongnam Institute of Radiological & Medical Sciences · KRDong-A University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol has received considerable attention as a polyphenol with various biological effects such as anti-inflammatory, anti-oxidant, anti-mutagenic, anti-carcinogenic, and cardioprotective properties. As part of the overall safety assessment of HS-1793, a novel resveratrol analogue free from the restriction of metabolic instability and the high dose requirement of resveratrol, we assessed genotoxicity in three in vitro assays: a bacterial mutation assay, a comet assay, and a chromosomal aberration assay. In the bacterial reverse mutation assay, HS-1793 did not increase revertant colony numbers in S. typhimurium strains (TA98, TA100, TA1535 and TA1537) or an E. coli strain (WP2 uvrA) regardless of metabolic activation. HS-1793 showed no evidence of genotoxic activity such as DNA damage on L5178Y Tk(+/-) mouse lymphoma cells with or without the S9 mix in the in vitro comet assay. No statistically significant differences in the incidence of chromosomal aberrations following HS-1793 treatment was observed on Chinese hamster lung cells exposed with or without the S9 mix. These results provide additional evidence that HS-1793 is non-genotoxic at the dose tested in three standard tests and further supports the generally recognized as safe determination of HS-1793 during early drug development.

Indexed as

Bacterial mutation assayChromosomal aberration assayComet assayGenotoxicityHS-1793Resveratrol

Identifiers

PMID25343016
PMCPMC4206749
OpenAlexW2024275433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.